The page on prostate cancer from Creative Biogene primarily focuses on diagnostic tools and services for prostate cancer detection and research. It highlights the use of rapid tests based on immunochromatographic methods to detect Prostate-Specific Antigen (PSA) levels in human serum, plasma, or blood. The tests have high sensitivity and specificity, making them effective for early detection of prostate cancer. Additionally, they offer parameters like cutoff levels (e.g., 3 ng/mL or 4 ng/mL depending on the test), accuracy rates, and their applications in both clinical and research contexts.

Creative Biogene also provides services in oncology diagnostics, such as molecular diagnostic tools, flow cytometry, enzyme-linked immunoassays, and chemiluminescence immunoassays, emphasizing their capability to support research and clinical needs in cancer detection and management.

For more details, you can visit their page: Creative Biogene - Prostate Cancer